The scoliosis management market is likely to record a CAGR of 3.9% during the forecast period, up from US$ 2,942.8 Million in 2022 to reach a valuation of US$ 4,489.0 Million by 2032.
The high prevalence of scoliosis, the high adoption rate of braces, and the progress of technology with tracking devices that can monitor the health of the patient are the primary factors driving the growth of the scoliosis management market. The demand for scoliosis management is also anticipated to be driven by the growing demand for minimally-invasive therapies.
As per the scoliosis management market study, the disease affects both sexes, but the progression of the curve is eight times greater in women than in men. However, as patients must wear the device for 22-23 hours a day, it stiffens their bodies, resulting in skin irritation and rashes. Additionally, it puts pressure on the chest and abdomen, which can lead to breathing difficulties and a reduction in oxygen delivery to the lungs. This is likely to hamper the growth of the scoliosis management market.
It is projected that the scoliosis management market would expand over the forecast period in addition to lower prices for braces, more public awareness is likely to boost the adoption of scoliosis management over during the forecast period.
| Attributes | Details |
|---|---|
| Estimated Market Value (2022) | US$ 2,942.8 Million |
| Forecasted Market Value (2032) | US$ 4,489.0 Million |
| CAGR (2022 to 2032) | 3.9% |
Among the key trends in the scoliosis management market, the progression of innovation with GPS beacons to screen patients are likely to remain dominant during the forecast period. The growth momentum of the scoliosis management market is further prompted by the high prevalence of the disease, advancements in the latest technologies, and rising support from governments. In addition, the scoliosis management market needs to be driven by an increasing need for therapies that do not involve invasive surgery.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scoliosis management market analysis indicates that there has been a significant increase in the number of people diagnosed with scoliosis around the world. Scoliosis affects an estimated 2-3 percent of the population in the United States alone, with an estimated six to nine million persons affected by the condition. Nearly 600,000 patients have visited private institutions, over 30,000 adolescents wear braces, and approximately 38,000 people have undergone spinal fusion surgery in the United States since 2010.
The scoliosis management market expansion is being fuelled by multiple factors high cost of therapy or procedures, can limit the scoliosis management market expansion. The shortage of competent specialists, poor payment regulations, and a lack of knowledge about the illness and available treatment choices are all limiting the overall demand for scoliosis management.
The TLSO product segment of the scoliosis management market is predicted to grow at a CAGR of 3.8 percent during the projection period, a remarkable achievement. The scoliosis management market is divided into three sections based on age groups infantile, adolescent, and young adult.
The entire scoliosis management market is likely to be dominated by the adolescent age group during the forecast period, with revenue expected to reach US$ 3,494.9 Million by 2028. Hospital pharmacies, retail pharmacies, and internet sales make up the three major segments of the global scoliosis management industry.
The online sales category of the scoliosis management market is predicted to develop at the fastest rate over the projection period in terms of distribution channels.
Principal Consultant
Over the course of the forecast period, it is anticipated that the scoliosis management market is expected to be led by North America, with a share of 39% in 2022.
After North America, Europe is the second-largest market with a scoliosis management market. The European scoliosis management market is likely to hold a market share of 23% by the end of 2022. As a result of the high adoption rate of braces in Western Europe, there has been a recent surge in the adoption of scoliosis management products. Over the course of the period covered by this forecast, the revenue growth of the scoliosis management market in Western Europe is anticipated to be boosted by an increase in demand for non-invasive treatments.
The increasing prevalence of idiopathic scoliosis and the support provided by governments in the form of funding and awareness initiatives are likely to be the primary drivers of growth in the scoliosis management market throughout the forecast period in Europe. The British Scoliosis Research Foundation provides research grants to qualified professionals for the purpose of conducting research in the field of scoliosis in the United Kingdom. As a result, it is anticipated that the development of treatment options for scoliosis in Europe is expected to flourish and the demand for scoliosis management is expected to improve.
With an increase in healthcare spending and an abundance of management alternatives, Asia-Pacific excluding Japan is expected to expand at the quickest CAGR during this projected period. In addition, the scoliosis management market is growing as a result of the region's constant technical advancements and new introductions. A shortage of qualified healthcare workers as well as low per capita healthcare spending in these regions, along with a lack of knowledge about the disease, are projected to keep the growth momentum in regions such as Latin America and the Middle East, and Africa during the projection year.
New innovations are leading the development of the scoliosis management market. Market players are increasingly focusing on devising more accessible products. The scoliosis management market is growing rapidly due to high research and development by companies.
As per the scoliosis management market study, a new spinal fusion technology product and the solution were introduced in the United States by Alphatec Spine Inc., a medical device company based in California that designs, develops, manufactures, and markets spinal fusion technology products and solutions. The new system is called the Arsenal Deformity Adolescent Idiopathic Scoliosis (AIS) System.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In order to maintain and increase their significant market shares in the scoliosis management market, market vendors are concentrating their efforts on the development of new technologies. By way of illustration, 3D Systems introduced its 3D-printed bespoke braces for the treatment of scoliosis. This is leading the global scoliosis management market.
Recent Developments
A significant number of companies that are active in the global scoliosis management market are concentrating their efforts on forming collaborations and partnerships with regional distributors and retailers in order to strengthen their position in international markets. Companies can improve their product visibility across a wider range of regions as a result of these collaborations and partnerships. Similarly, the companies that are currently in the scoliosis management market are placing a significant emphasis on investing in product innovation in order to bolster their presence in markets all over the world.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 3.9% from 2022 to 2032 |
| The base year for estimation | 2021 |
| Historical data | 2016 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD billion and CAGR from 2022 to 2032 |
| Report Coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments Covered | Disease, Age, Product, Distribution Channels, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia, and New Zealand |
| Country scope | United States of America; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Boston Orthotics & Prosthetics, Chaneco, Original Bending Brace, Orthotech, Trulife, L.A. Brace, Össur, DJO, LLC, Wilmington Orthotics & Prosthetics, Inc., Lawall Prosthetics and Orthotics, Horton's Orthotics & Prosthetics, Aspen Medical Products, UNYQ, C H Martin Company, Optec USA, Inc., Spinal Technology, Inc., Ortholutions GmbH & Co. KG, Wellinks, Inc., and Pro-Tech Orthopedics. |
| Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The scoliosis management market is likely to register a CAGR of 3.9% during the forecast period.
As per the analysis, the scoliosis management market share is likely to be US$ 4,489.0 Million by 2032.
The constant progression of technology is the key driver in the industry.
1. Executive Summary | Scoliosis Management Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Disease Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Disease Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Type, 2022 to 2032 5.3.1. Infantile Idiopathic Scoliosis 5.3.2. Juvenile Idiopathic Scoliosis 5.3.3. Adolescent Idiopathic Scoliosis 5.4. Y-o-Y Growth Trend Analysis By Disease Type, 2017 to 2021 5.5. Absolute Opportunity Analysis By Disease Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Age 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Age, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Age, 2022 to 2032 6.3.1. Pediatric 6.3.2. Adult 6.4. Y-o-Y Growth Trend Analysis By Age, 2017 to 2021 6.5. Absolute Opportunity Analysis By Age, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032 7.3.1. Cervical Thoracic Lumbar Sacral Orthosis (CTLSO) 7.3.2. Thoracolumbosacral Orthosis (TLSO) 7.3.3. Lumbosacral Orthosis (LSO) 7.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021 7.5. Absolute Opportunity Analysis By Product Type, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channels 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channels, 2017 to 2021 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channels, 2022 to 2032 8.3.1. Hospitals & Clinics 8.3.2. Retail Pharmacies 8.3.3. Online Pharmacies 8.4. Y-o-Y Growth Trend Analysis By Distribution Channels, 2017 to 2021 8.5. Absolute Opportunity Analysis By Distribution Channels, 2022 to 2032 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. United States of America 10.2.1.2. Canada 10.2.2. By Disease Type 10.2.3. By Age 10.2.4. By Product Type 10.2.5. By Distribution Channels 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Disease Type 10.3.3. By Age 10.3.4. By Product Type 10.3.5. By Distribution Channels 10.4. Key Takeaways 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Disease Type 11.2.3. By Age 11.2.4. By Product Type 11.2.5. By Distribution Channels 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Disease Type 11.3.3. By Age 11.3.4. By Product Type 11.3.5. By Distribution Channels 11.4. Key Takeaways 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Disease Type 12.2.3. By Age 12.2.4. By Product Type 12.2.5. By Distribution Channels 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Disease Type 12.3.3. By Age 12.3.4. By Product Type 12.3.5. By Distribution Channels 12.4. Key Takeaways 13. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. India 13.2.1.5. Malaysia 13.2.1.6. Singapore 13.2.1.7. Australia 13.2.1.8. New Zealand 13.2.1.9. Rest of Asia-Pacific (APAC) 13.2.2. By Disease Type 13.2.3. By Age 13.2.4. By Product Type 13.2.5. By Distribution Channels 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Disease Type 13.3.3. By Age 13.3.4. By Product Type 13.3.5. By Distribution Channels 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of Middle East and Africa 14.2.2. By Disease Type 14.2.3. By Age 14.2.4. By Product Type 14.2.5. By Distribution Channels 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Disease Type 14.3.3. By Age 14.3.4. By Product Type 14.3.5. By Distribution Channels 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. United States of America 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Disease Type 15.1.2.2. By Age 15.1.2.3. By Product Type 15.1.2.4. By Distribution Channels 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Disease Type 15.2.2.2. By Age 15.2.2.3. By Product Type 15.2.2.4. By Distribution Channels 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Disease Type 15.3.2.2. By Age 15.3.2.3. By Product Type 15.3.2.4. By Distribution Channels 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Disease Type 15.4.2.2. By Age 15.4.2.3. By Product Type 15.4.2.4. By Distribution Channels 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Disease Type 15.5.2.2. By Age 15.5.2.3. By Product Type 15.5.2.4. By Distribution Channels 15.6. United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Disease Type 15.6.2.2. By Age 15.6.2.3. By Product Type 15.6.2.4. By Distribution Channels 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Disease Type 15.7.2.2. By Age 15.7.2.3. By Product Type 15.7.2.4. By Distribution Channels 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Disease Type 15.8.2.2. By Age 15.8.2.3. By Product Type 15.8.2.4. By Distribution Channels 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Disease Type 15.9.2.2. By Age 15.9.2.3. By Product Type 15.9.2.4. By Distribution Channels 15.10. China 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Disease Type 15.10.2.2. By Age 15.10.2.3. By Product Type 15.10.2.4. By Distribution Channels 15.11. Japan 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Disease Type 15.11.2.2. By Age 15.11.2.3. By Product Type 15.11.2.4. By Distribution Channels 15.12. South Korea 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Disease Type 15.12.2.2. By Age 15.12.2.3. By Product Type 15.12.2.4. By Distribution Channels 15.13. Malaysia 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Disease Type 15.13.2.2. By Age 15.13.2.3. By Product Type 15.13.2.4. By Distribution Channels 15.14. Singapore 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Disease Type 15.14.2.2. By Age 15.14.2.3. By Product Type 15.14.2.4. By Distribution Channels 15.15. Australia 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Disease Type 15.15.2.2. By Age 15.15.2.3. By Product Type 15.15.2.4. By Distribution Channels 15.16. New Zealand 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Disease Type 15.16.2.2. By Age 15.16.2.3. By Product Type 15.16.2.4. By Distribution Channels 15.17. GCC Countries 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Disease Type 15.17.2.2. By Age 15.17.2.3. By Product Type 15.17.2.4. By Distribution Channels 15.18. South Africa 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Disease Type 15.18.2.2. By Age 15.18.2.3. By Product Type 15.18.2.4. By Distribution Channels 15.19. Israel 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Disease Type 15.19.2.2. By Age 15.19.2.3. By Product Type 15.19.2.4. By Distribution Channels 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Disease Type 16.3.3. By Age 16.3.4. By Product Type 16.3.5. By Distribution Channels 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Boston Orthotics & Prosthetics 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Chaneco 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Original Bending Brace 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Orthotech 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Trulife 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. L.A. Brace 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Össur 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Wilmington Orthotics & Prosthetics Inc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Lawall Prosthetics and Orthotics 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Horton's Orthotics & Prosthetics 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Scoliosis Management Market
